Lumipulse® G SARS-CoV-2 Ag included in EU’s common list of COVID-19 laboratory based antigenic assays

Product news

The Lumipulse G SARS-CoV-2 Ag assay is included in the list of mutually recognised COVID-19 laboratory based antigenic assay as agreed by the Health Security Committee from the European commission for health and food safety and EU Member States, the latest update being on April 8, 2022.

With this inclusion the Lumipulse G SARS-CoV-2 Ag test is acknowledged as a good quality assay fulfilling all validation requirements on clinical performance as reported by independent validation studies showing an excellent sensitivity and specificity. 

The full list is available on the website of the European Commission.

More information about the Lumipulse G SARS-CoV-2 Ag can be found here.